California State Teachers Retirement System Angion Biomedica Corp. Transaction History

California State Teachers Retirement System

  • $84.1 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.1 - $2.23 $10,520 - $21,327
-9,564 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$1.72 - $2.96 $3,770 - $6,488
-2,192 Reduced 18.65%
9,564 $20,000
Q4 2021

Feb 15, 2022
SELL
$2.35 - $9.95 $14 - $59
-6 Reduced 0.05%
11,756 $34,000
Q3 2021

Nov 15, 2021
BUY
$9.31 - $13.25 $34,605 - $49,250
3,717 Added 46.2%
11,762 $115,000
Q2 2021

Aug 16, 2021
SELL
$13.02 - $17.83 $9,257 - $12,677
-711 Reduced 8.12%
8,045 $105,000
Q1 2021

May 18, 2021
BUY
$15.01 - $25.74 $131,427 - $225,379
8,756 New
8,756 $158,000

About Angion Biomedica Corp.

ANGN Quotes by TradingView
  • Ticker ANGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,113,300
  • Description
  • Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...
More about ANGN
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email